Ayşegül A. Şahin

The University of Texas MD Anderson Cancer Center — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

105h-index42.2kcitations844works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(213), Breast Lesions and Carcinomas(138), HER2/EGFR in Cancer Research(125), Cancer Genomics and Diagnostics(125), Cancer Cells and Metastasis(98)

Publications843 total

Supplemental Figures and Figure Legends from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
2025Open Access
Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach
Clinical Cancer Research·2025· 1 citedOpen Access
Supplementary Table 1 from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
2025Open Access
Supplementary Materials and Methods from Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers
2025Open Access
<scp>TRPS1</scp> expression in neuroendocrine neoplasms of breast and other organs
Histopathology·2025
Association between p16INK4A expression and a treatment response to CDK4/6 inhibitor in advanced breast carcinoma
Human Pathology·2025
Emerging molecular Therapeutic targets in breast Cancer: Pathologic identification and clinical implications
Human Pathology·2025
IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer
npj Precision Oncology·2025· 4 citedOpen Access
Abstract P4-04-19: Characterizing Nanomechanical Properties of Skin and Soft Tissue in Postmastectomy Implant Reconstruction
Clinical Cancer Research·2025
Abstract PS13-07: Enhancing T-DXd Efficacy in HER2-positive Breast Cancer Resistant to HER2 ADC by Non-biased Kinase-related Target Screening
Clinical Cancer Research·2025
Updates on utility of immunohistochemistry in diagnosis of metastatic breast cancer
Human Pathology·2025· 1 cited
Upregulation of MMP9 expression in postradiation angiosarcoma of the breast: a possible predictive risk factor
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin·2025· 1 cited
3718 Findings of the PROTIEUS trial pre-accrual quality assurance contouring assessment – the importance of the benchmark case
Radiotherapy and Oncology·2025
Predictive biomarkers for immune checkpoint inhibitor (ICI) and poly (ADP-ribose) polymerase (PARP) inhibitor (PARPi) in advanced-stage breast carcinoma
Human Pathology Reports·2025Open Access
Abstract LB403: Characterizing nanomechanical properties of skin tissue in postmastectomy implant reconstruction
Cancer Research·2025
Abstract 4613: Differential TROP2 immunohistochemical expression between pleomorphic and classic invasive lobular carcinoma of the breast
Cancer Research·2025
Malignant phyllodes tumours of the breast: the case for revising <scp>WHO’</scp>s ‘full house’ diagnostic criteria
Histopathology·2025· 8 citedOpen Access
Supplementary Table S1 from Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer
2025Open Access
Supplementary Table S4 from Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer
2025Open Access
Data from Human Epidermal Growth Factor Receptor 2 Loss following Treatment with Trastuzumab Deruxtecan in Patients with Metastatic Breast Cancer
2025Open Access
page 1 of 43Next →

Frequent Co-authors

Gabriel N. Hortobágyi(26), Mien‐Chie Hung(12), Kelly K. Hunt(11), Dihua Yu(10), Aman U. Buzdar(10), S. Eva Singletary(8), Thomas A. Buchholz(8), Vicente Valero(8), Funda Meric‐Bernstam(8), Henry M. Kuerer(8), Weiya Xia(6), Ana M. González-Angulo(6), Merrick I. Ross(6), Francisco J. Esteva(5), Richard L. Theriault(5), Jun Yao(5), Yun Wu(5), Gordon B. Mills(5), Ratna K. Vadlamudi(5), Lajos Pusztai(4)